TP53 and neoplasm: Intraperitoneal injection of Trp53‐null ID8 cells increases tumour growth rate and decreases survival compared with parental cells (Walton et al, 2016), showing that Trp53 loss alone does cause in vivo functional differences to tumorigenesis.